KOLs have traditionally exerted their influence through research and publication on drug safety and efficacy, but now share the stage with other important measures.
Paul Chew, MD
Advertisement
Articles by Paul Chew, MD
Clinical Trials Don't Have to Cost Too Much or Take Too Long
Published: | Updated:
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Clinical Trials Don't Have to Cost Too Much or Take Too LongPublished: May 8th 2018 | Updated: November 15th 2020
- KOLs: An Endangered Buzzword
Published: March 20th 2019 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5